Johnson & Johnson Aiming to Enroll One-Third of Phase 3 Trial Patients From Latin AmericaThe Motley Fool • 09/05/20
Moderna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political PressureThe Motley Fool • 09/05/20
Johnson & Johnson Coronavirus Vaccine Candidate Shows Encouraging Results in Animal TrialThe Motley Fool • 09/04/20
As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval24/7 Wall Street • 09/02/20
FDA Head Says A COVID-19 Vaccine Could Get Emergency Approval Without Phase 3 Trial Results: FTBenzinga • 08/31/20
Johnson & Johnson: Accelerating Their Virus Vaccine Development And The Buy Of Momenta With Debt Is A Good MoveSeeking Alpha • 08/25/20